We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DSSA:IDXPT Dian Swastatika Sentosa Tbk Analysis

Data as of 2026-06-19 - not real-time

IDR 800.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at IDR 800, well below its 52‑week high of 4,720 but still above the recent support of 410. Price sits under the 20‑day (639.65), 50‑day (1,458.06) and 200‑day (3,249.20) moving averages, signaling a persistent bearish bias. Technical momentum is mixed: RSI is around 43 (neutral), while the MACD histogram is positive, indicating a short‑term bullish flare, yet the overall trend remains down‑trend with high 30‑day volatility of 167% and a beta of 1.54. The recent news of a 14% plunge to a two‑year low underscores market pressure.
Fundamentally, the company appears overvalued – a PE of 31.9 versus the industry average of 20.1, a price‑to‑book of 66,667, and a DCF fair value of only 0.0137 IDR per share. Margins are modest (gross 33%, operating 15.6%, profit 8.3%) and cash generation is weak, with negative free cash flow and a debt‑to‑equity of 65.7%. No dividend is paid, and the business faces high sector and regulatory headwinds as a thermal‑coal operator. The combination of technical weakness, inflated valuation, and structural challenges suggests caution.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below all major SMAs indicating bearish trend
  • Recent 14% price collapse to a two‑year low
  • Extreme short‑term volatility and high beta

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Overvalued multiples relative to peers
  • Negative free cash flow and high leverage
  • Sector headwinds for thermal coal

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Structural shift away from coal and renewable transition risk
  • Persistently weak cash generation and debt burden
  • Valuation far above DCF fair value and lack of dividend

Key Metrics & Analysis

Financial Health

Revenue Growth-0.50%
Profit Margin8.26%
P/E Ratio31.9
ROE17.18%
ROA6.18%
Debt/Equity65.72
P/B Ratio66666.7
Op. Cash FlowIDR329.7M
Free Cash FlowIDR-205732208
Industry P/E20.1

Technical Analysis

TrendBearish
RSI43.3
SupportIDR 410.00
ResistanceIDR 895.00
MA 20IDR 639.65
MA 50IDR 1,458.06
MA 200IDR 3,249.20
MACDBullish
VolumeStable
Fear & Greed Index92.14

Valuation

Fair ValueIDR 0.01
GradeOvervalued
TypeValue

Risk Assessment

Beta1.54
Volatility167.71%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.